Latest & greatest articles for Anaphylaxis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Anaphylaxis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Anaphylaxis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Anaphylaxis

41. Anaphylaxis and allergic reactions in children

most common cause. Bees may leave a venom sac which should Insect sting- be scraped off (not squeezed). induced Injected allergens commonly anaphylaxis result in cardiovascular compromise, with hypotension and shock predominating. Medications, particularly penicillin, account for a large Drug-induced percentage of anaphylactic anaphylaxis reactions. Slow release drugs prolong absorption and exposure to the allergen. Other causes Latex, and exercise. For background and pathphysiology of anaphylaxis (...) ? possible continuing absorption of the allergen ? previous history of biphasic reactions. Key Points – Anaphylaxis in children ? Anaphylaxis may be dif?cult to diagnose. ? Remove the allergen. ? Epinephrine is the mainstay of treatment. ? Reactions may recur. ? Hydrocortisone is not part of the immediate treatment. REFERENCES 1 Chamberlain D. Emergency medical treatment of anaphylactic reactions. Project Team of the Resuscitation Council (UK). J Accid Emerg Med 1999 16(4):243-247. 2 Revell M, Porter K

2006 Joint Royal Colleges Ambulance Liaison Committee

42. Anaphylaxis / allergic reactions in adults

and clinical immunology 2004;114(2):371-6. 2 Kane KE, Cone DC. Anaphylaxis in the pre-hospital setting. The Journal of emergency medicine 2004;27(4):371-7. 3 McLean-Tooke AP , Bethune CA, Fay AC, Spickett GP . Adrenaline in the treatment of anaphylaxis: what is the evidence? BMJ 2003;327(7427):1332-5. 4 Chamberlain D, Fisher J, Ward M, Cant A, Dawson P , Ewan P , et al. The Emergency Medical Treatment of Anaphylactic Reactions for First Medical Responders and for Community Nurses Resuscitation Council (UK (...) ):584-91. 10 Thompson K, Chandra R. The management and prevention of food anaphylaxis. Nutrition Research 2002;22:89-110. 11 Af?liation: Royal College of Paediatrics and Child Health UKCAPToTRC. Update on the emergency medical treatment of anaphylactic reactions for ?rst medical responders and for community nurses. Resuscitation 2001;48(3):241-3. 12 Project Team of The Resuscitation Council (UK). Update on the emergency medical treatment of anaphylactic reactions for ?rst medical responders

2006 Joint Royal Colleges Ambulance Liaison Committee

43. Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review

Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 DARE.

44. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers

Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers BestBets: Glucagon infusion in anaphylactic shock in patients on beta-blockers Glucagon infusion in anaphylactic shock in patients on beta-blockers Report By: Martin Thomas - Specialist Registrar Search checked by Ian Crawford - Senior Clinical Fellow Institution: Manchester Royal Infirmary Date Submitted: 1st March 2000 Date Completed: 12th April 2005 Last Modified: 6th January 2005 Status: Green (complete) Three (...) Part Question In [anaphylactic shock for patients on regular beta-blockers] does [the use of a glucagon infusion] improve [outcome]? Clinical Scenario A 53 year old man attends the emergency department with a severe allergic reaction, having been stung by a wasp. You note that he takes atenolol for angina. Despite adequate treatment with adrenaline and intravenous fluids, he remains hypotensive and subsequently dies. Afterwards, you hear that a glucagon infusion may have been of benefit and wonder

2005 BestBETS

45. The diagnosis and management of anaphylaxis: an updated practice parameter.

The diagnosis and management of anaphylaxis: an updated practice parameter. Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You are here Guidelines and Measures Funding

2005 Joint Council of Allergy, Asthma and Immunology

46. Sequential randomised and double blind trial of promethazine prophylaxis against early anaphylactic reactions to antivenom for bothrops snake bites. Full Text available with Trip Pro

Sequential randomised and double blind trial of promethazine prophylaxis against early anaphylactic reactions to antivenom for bothrops snake bites. To investigate the efficacy of the H1 antihistamine promethazine against early anaphylactic reactions to antivenom.Sequential randomised, double blind, placebo controlled trial.Public hospital in a venom research institute, São Paulo, Brazil.101 patients requiring antivenom treatment after being bitten by bothrops snakes.Intramuscular injection (...) of promethazine (25 mg for adults and 0.5/kg for children) or placebo given 15-20 min before starting intravenous infusion of antivenom.Incidence and severity of anaphylactic reactions occurring within 24 hours after antivenom.Reactions occurred in 12 of 49 patients treated with promethazine (24%) and in 13 of 52 given placebo (25%); most were mild or moderate. Continuous sequential analysis indicated that the study could be interrupted at the 22nd untied pair, without preference for promethazine

1999 BMJ Controlled trial quality: predicted high

47. Idiopathic anaphylaxis: long-term follow-up, cost, and outlook

Idiopathic anaphylaxis: long-term follow-up, cost, and outlook Idiopathic anaphylaxis: long-term follow-up, cost, and outlook Idiopathic anaphylaxis: long-term follow-up, cost, and outlook Krasnick J, Patterson R, Harris K E Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability (...) of the study and the conclusions drawn. Health technology Oral corticosteroids, antihistamines and sympathomimetics in the treatment of patients with idiopathic anaphylaxis. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population Patients with idiopathic anaphylaxis. Setting Hospital. The economic study was carried out in Chicago, Illinois, USA. Dates to which data relate The data for the effectiveness analysis and resource use corresponded to the period between

1996 NHS Economic Evaluation Database.